Detalhe da pesquisa
1.
Survival factor NFIL3 restricts FOXO-induced gene expression in cancer.
Genes Dev
; 27(8): 916-27, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23630076
2.
Metformin and erlotinib synergize to inhibit basal breast cancer.
Oncotarget
; 5(21): 10503-17, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361177
3.
Scaffold hopping approach on the route to selective tankyrase inhibitors.
Eur J Med Chem
; 87: 611-23, 2014 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25299683
4.
Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells.
Cancer Biol Ther
; 14(3): 246-53, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23291982
5.
Brachyury: a new player in promoting breast cancer aggressiveness.
J Natl Cancer Inst
; 106(5)2014 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24815862
6.
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Cancer Res
; 69(11): 4674-81, 2009 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19470766
7.
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.
Nat Genet
; 40(1): 102-7, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18066063
8.
p63 regulates commitment to the prostate cell lineage.
Proc Natl Acad Sci U S A
; 102(32): 11355-60, 2005 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-16051706